Showing results (961-970 of 3,886) with videos related to
Sort By:
Pageof 389
Cancer Biology & Therapy|March 9, 2016
PD-1/PD-L1 expression in non-small-cell lung cancer and its correlation with EGFR/KRAS mutationsMei Ji, Yan Liu, Qing Li, et al.Cancer Biology & Therapy|May 24, 2012
A feasibility study on gene therapy of pancreatic carcinoma with Ad-PUMAHaijuan Wang, Wei Pei, Qingchun Luan, et al.Cancer Biology & Therapy|December 24, 2014
Aromatase inhibitor plus ovarian suppression as adjuvant therapy in premenopausal women with breast cancerWilliam D Figg, Katherine Cook, Robert ClarkeCancer Biology & Therapy|December 24, 2014
Recurrent FGFR3-TACC3 fusion gene in nasopharyngeal carcinomaLi Yuan, Zhi-Hua Liu, Zhi-Rui Lin, et al.Cancer Biology & Therapy|October 24, 2013
Continuous low-dose irradiation by I-125 seeds induces apoptosis of gastric cancer cells regardless of histological originKaoru Takabayashi, Kazuhiro Kashiwagi, Tetsuya Kawata, et al.Cancer Biology & Therapy|October 24, 2013
Role of chemokines and their receptors in chronic lymphocytic leukemia: function in microenvironment and targeted therapyTing-Ting Han, Lei Fan, Jian-Yong Li, et al.Cancer Biology & Therapy|June 14, 2013
Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patientsCirino Botta, Vito Barbieri, Domenico Ciliberto, et al.Cancer Biology & Therapy|June 14, 2013
Oral paricalcitol (19-nor-1,25-dihydroxyvitamin D2) in women receiving chemotherapy for metastatic breast cancer: a feasibility trialJulia A Lawrence, Steven A Akman, Susan A Melin, et al.Cancer Biology & Therapy|June 14, 2013
Establishment of an ASPL-TFE3 renal cell carcinoma cell line (S-TFE)Megumi Hirobe, Naoya Masumori, Toshiaki Tanaka, et al.Cancer Biology & Therapy|June 14, 2013
Evaluation of a reductively activated duocarmycin prodrug against murine and human solid cancersGeorge A Vielhauer, Megan Swink, Nikhil K Parelkar, et al.Pageof 389